Loading
IR
Immune Response Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Hochman David P, was filed 25 Aug 2006.
Immune Response Corp: what insiders have been doing
Immune Response Corp is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Immune Response Corp has published a filing in the past twelve months. The most recent one dates from 13 March 2008.
Since 2006, the database holds 5 purchases and 14 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€70,188
5 ops. · all time
Sell Volume
€17M
14 ops. · all time
Last declaration on 13 March 2008
Declarations40 total
560,000 sharesCommon StockSEC:0000898432-08-000278:0
600,000 sharesCommon StockSEC:0000898432-07-001026:0
700,000 sharesCommon StockSEC:0000898432-07-000961:0
500,000 sharesCommon StockSEC:0000898432-07-000902:0
600,000 sharesCommon StockSEC:0000898432-07-000902:1
355,000 shares@ US$1.99Common StockSEC:0001294002-07-000005:0
333,000 shares@ US$1.95Common StockSEC:0001294002-07-000005:1
1,041,000 shares@ US$1.96Common StockSEC:0001294002-07-000005:2
1,042,500 shares@ US$1.92Common StockSEC:0001294002-07-000005:3
158,000 shares@ US$1.91Common StockSEC:0001294002-07-000005:4
325,600 shares@ US$1.91Common StockSEC:0001294002-07-000005:5
1,770,000 shares@ US$1.90Common StockSEC:0001294002-07-000005:6
2,474,900 shares@ US$1.92Common StockSEC:0001294002-07-000005:7
250,000 shares@ US$2.00Common StockSEC:0001294002-07-000006:0
250,000 shares@ US$2.00Common StockSEC:0001294002-07-000006:1
200,000 shares@ US$2.00Common StockSEC:0001294002-07-000006:2
2,180,000 shares@ US$2.00Common StockSEC:0001294002-07-000006:3
150,000 shares@ US$2.00Common StockSEC:0001294002-07-000006:4
720,000 shares@ US$2.00Common StockSEC:0001294002-07-000006:5
43,749 shares@ US$0.08Common StockSEC:0001294002-06-000036:0
45,455 shares@ US$0.11Common StockSEC:0001294002-06-000036:1
250,002 shares@ US$0.02Common StockSEC:0001294002-06-000036:2
249,996 shares@ US$0.02Common StockSEC:0001294002-06-000036:3
6,016 shares@ US$0.08Common StockSEC:0001294002-06-000039:0
4,574 shares@ US$0.11Common StockSEC:0001294002-06-000039:1
25 of 40 declarations
About Immune Response Corp
Immune Response Corp is a company listed on the XNAS market, specializing in the development of immunological treatments. It focuses on innovative solutions for autoimmune diseases and viral infections.
